Sign Out
Pregnancy: Category C. Olopatadine was not found to be teratogenic in rats and rabbits. There are no adequate and well controlled studies in pregnant women. Use this drug in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus.
Lactation: Olopatadine has been identified in milk of nursing rats following oral administration. It is not known whether topical ocular administration could result in sufficient systemic absorption to produce detectable quantities in breast milk. Exercise caution when olopatadine is administered to a nursing women.
